Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted gene editing by transfection ofin vitroreconstitutedStreptococcus thermophilusCas9 nuclease complex

2 Jan 2015

Abstract excerpt

Cas9 protein of the Type II CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated)1 bacterial adaptive immune system emerged recently as a promising tool for genom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Cytomegalovirus and herpesvirus research
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25826410
DOI: 10.1080/15476286.2015.1017209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted gene editing by transfection ofin vitroreconstitutedStreptococcus thermophilusCas9 nuclease complexPMID 25826410Read ↗

CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseasesSemantic proximity Read ↗

CRISPR /Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunitySemantic proximity Read ↗

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell TherapySemantic proximity Read ↗

The Bacterial Origins of the CRISPR Genome-Editing RevolutionSemantic proximity Read ↗

Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer ManagementSemantic proximity Read ↗

Challenges of CRISPR-Based Gene Editing in Primary T CellsSemantic proximity Read ↗

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapySemantic proximity Read ↗

Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapySemantic proximity Read ↗

CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methodsSemantic proximity Read ↗

Challenges of CRISPR-based Gene Editing in Primary T CellsSemantic proximity Read ↗

CRISPR–Cas9 applications in T cells and adoptive T cell therapiesSemantic proximity Read ↗

Diversity of CRISPR-Cas immune systems and molecular machines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.